儿童期诊断的高胰岛素性低血糖可为单基因病因
研究对1848例高胰岛素血症患者进行已知致病基因筛查,其中儿童期起病(1-16岁诊断)者单基因病因检出率为24%(42/173),显著低于婴儿期起病者的74.5%(1248/1675,P<0.00001)。儿童期确诊单基因高胰岛素血症者中75%在2.7岁前诊断,81%的儿童期队列变异也见于婴儿期诊断者。作者认为单基因高胰岛素血症是婴儿期外起病的重要病因,无论诊断年龄均应考虑基因检测。
要点
- 儿童期起病高胰岛素血症单基因病因检出率为24%(42/173),显著低于婴儿期的74.5%(1248/1675),P<0.00001。
- 75%的儿童期确诊单基因高胰岛素血症者在2.7岁前诊断,提示多为年龄分布尾端。
- 儿童期队列中81%的变异也见于婴儿期诊断者,支持上述解释。
核心结论
- 单基因高胰岛素血症是婴儿期外起病的重要病因,对持续性高胰岛素血症儿童无论诊断年龄均应考虑基因检测。
研究设计与样本
- 对1848例高胰岛素血症患者进行已知致病基因筛查,按诊断年龄分为婴儿期起病(<12月龄)和儿童期起病(1-16岁)。
主要发现
- 儿童期起病队列单基因病因检出率为24%(42/173),婴儿期起病队列为74.5%(1248/1675),差异显著(P<0.00001)。
- 儿童期确诊单基因高胰岛素血症者中75%在2.7岁前诊断。
- 儿童期队列中81%的变异在婴儿期诊断者中也被检出。
临床怎么用
- 作者建议对持续性高胰岛素血症儿童无论诊断年龄均应考虑基因检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Congenital hyperinsulinism (HI) is characterized by inappropriate insulin secretion despite low blood glucose. Persistent HI is often monogenic, with the majority of cases diagnosed in infancy. Less is known about the contribution of monogenic forms of disease in those presenting in childhood. OBJECTIVE: We investigated the likelihood of finding a genetic cause in childhood-onset HI and explored potential factors leading to later age at presentation of disease. METHODS: We screened known disease-causing genes in 1848 individuals with HI, referred for genetic testing as part of routine clinical care. Individuals were classified as infancy-onset (diagnosed with HI < 12 months of age) or childhood-onset (diagnosed at age 1-16 years). We assessed clinical characteristics and the genotypes of individuals with monogenic HI diagnosed in childhood to gain insights into the later age at diagnosis of HI in these children. RESULTS: We identified the monogenic cause in 24% (n = 42/173) of the childhood-onset HI cohort; this was significantly lower than the proportion of genetic diagnoses in infancy-onset cases (74.5% [n = 1248/1675], P < 0.00001). Most (75%) individuals with genetically confirmed childhood-onset HI were diagnosed before 2.7 years, suggesting these cases represent the tail end of the normal distribution in age at diagnosis. This is supported by the finding that 81% of the variants identified in the childhood-onset cohort were detected in those diagnosed in infancy. CONCLUSION: We have shown that monogenic HI is an important cause of hyperinsulinism presenting outside of infancy. Genetic testing should be considered in children with persistent hyperinsulinism, regardless of age at diagnosis.
引用
- Hopkins JJ, Childs AJ, Houghton JAL, et al. Hyperinsulinemic Hypoglycemia Diagnosed in Childhood Can Be Monogenic. J Clin Endocrinol Metab. 2023. PMID: 36239000. doi:10.1210/clinem/dgac604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。